Showing results (461-470 of 7,003) with videos related to

Sort By:
Pageof 701
Lung Cancer (Amsterdam, Netherlands)|August 4, 2006
A phase II study with gemcitabine and split-dose cisplatin in patients with advanced non-small cell lung cancerJung Han Kim, Dong Hun Lee, Hyun Chun Shin, et al.
Lung Cancer (Amsterdam, Netherlands)|August 29, 2006
Multidrug resistance in small cell lung cancer: expression of P-glycoprotein, multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed diseaseNadja Triller, Peter Korosec, Izidor Kern, et al.
Lung Cancer (Amsterdam, Netherlands)|August 29, 2006
Eg5 expression is closely correlated with the response of advanced non-small cell lung cancer to antimitotic agents combined with platinum chemotherapyTakamoto Saijo, Genichiro Ishii, Atsushi Ochiai, et al.
Lung Cancer (Amsterdam, Netherlands)|June 23, 2006
Rational drug sequencing of paclitaxel, gemcitabine and carboplatin in patients with untreated stage IV and select stage IIIB non-small cell lung cancerMika A Sovak, Stuart Lutzker, Ling Zheng, et al.
Lung Cancer (Amsterdam, Netherlands)|October 3, 2006
Gastro-intestinal metastasis of primary lung carcinoma: clinical presentations and outcomeChih-Jen Yang, Jhi-Jhu Hwang, Wang-Yi Kang, et al.
Lung Cancer (Amsterdam, Netherlands)|October 4, 2006
Polymorphisms in the FAS and FASL genes and risk of lung cancer in a Korean populationSun Ha Park, Jin Eun Choi, Eun Jin Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|October 3, 2006
Induction cisplatin-gemcitabine-paclitaxel plus concurrent radiotherapy and gemcitabine in the multimodality treatment of unresectable stage IIIB non-small cell lung cancerL Trodella, F De Marinis, R M D'Angelillo, et al.
Lung Cancer (Amsterdam, Netherlands)|October 3, 2006
Clinicopathologic features and prognostic implications of epidermal growth factor receptor (EGFR) gene copy number and protein expression in non-small cell lung cancerYoon Kyung Jeon, Sook-Whan Sung, Jin-Haeng Chung, et al.
Lung Cancer (Amsterdam, Netherlands)|June 30, 2006
A phase I and pharmacological study of amrubicin and topotecan in patients of small-cell lung cancer with relapsed or extensive-disease small-cell lung cancerTakuo Shibayama, Katsuyuki Hotta, Nagio Takigawa, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2006
Expression and prognostic implications of apoptosis-related proteins in locally unresectable non-small cell lung cancersEelco Fokkema, Wim Timens, Elisabeth G E de Vries, et al.
Pageof 701